Viking Therapeutics, Inc.

Direct answer

Viking Therapeutics, Inc. is publicly traded on NASDAQ under the ticker VKTX.

Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting...

Can you invest in Viking Therapeutics, Inc.?

Yes. Viking Therapeutics, Inc. is publicly traded on NASDAQ under the ticker VKTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Viking Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.